Frequency of coexistent eye diseases and cognitive impairment or dementia: a systematic review and meta-analysis.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
10 2023
Historique:
received: 14 04 2022
accepted: 28 02 2023
revised: 20 01 2023
medline: 12 10 2023
pubmed: 17 3 2023
entrez: 16 3 2023
Statut: ppublish

Résumé

We aim to quantify the co-existence of age-related macular degeneration (AMD), glaucoma, or diabetic retinopathy (DR) and cognitive impairment or dementia. MEDLINE, EMBASE, PsycINFO and CINAHL were searched (to June 2020). Observational studies reporting incidence or prevalence of AMD, glaucoma, or DR in people with cognitive impairment or dementia, and of cognitive impairment or dementia among people with AMD, glaucoma, or DR were included. Fifty-six studies (57 reports) were included but marked by heterogeneities in the diagnostic criteria or definitions of the diseases, study design, and case mix. Few studies reported on the incidence. Evidence was sparse but consistent in individuals with mild cognitive impairment where 7.7% glaucoma prevalence was observed. Prevalence of AMD and DR among people with cognitive impairment ranged from 3.9% to 9.4% and from 11.4% to 70.1%, respectively. Prevalence of AMD and glaucoma among people with dementia ranged from 1.4 to 53% and from 0.2% to 25.9%, respectively. Prevalence of DR among people with dementia was 11%. Prevalence of cognitive impairment in people with AMD, glaucoma, and DR ranged from 8.4% to 52.4%, 12.3% to 90.2%, and 3.9% to 77.8%, respectively, and prevalence of dementia in people with AMD, glaucoma and DR ranged from 9.9% to 62.6%, 2.5% to 3.3% and was 12.5%, respectively. Frequency of comorbid eye disease and cognitive impairment or dementia varied considerably. While more population-based estimations of the co-existence are needed, interdisciplinary collaboration might be helpful in the management of these conditions to meet healthcare needs of an ageing population. PROSPERO registration: CRD42020189484. 摘要: 目的: 我们旨在量化老年黄斑变性 (AMD) 、青光眼或糖尿病视网膜疾病合并认知障碍或痴呆情况。 方法: 本文检索了MEDLINE、EMBASE、PsycINFO和CINAHL (至2020年6月) 数据库。观察性研究报道了认知障碍或痴呆患者中AMD、青光眼或糖尿病视网膜病变 (DR) 的发病率或流行率, 以及AMD、青光眼或DR患者中认知障碍或痴呆的情况。 结果: 本文共纳入了56项研究 (57份报告), 这些研究在疾病的诊断标准或定义、研究设计和病例组合方面存在着异质性。很少研究报告发病率。虽然证据少, 但在轻度认知障碍者中的证据是连续的, 观察到7.7%的青光眼发病率。认知障碍者中AMD和DR的患病率分别为3.9%至9.4%和11.4%至70.1%。痴呆症患者中AMD和青光眼的患病率分别为1.4%至53%和0.2%至25.9%。痴呆症患者中DR的患病率为11%。 患有AMD、青光眼和DR的人中认知障碍的发病率分别为8.4%至52.4%、12.3%至90.2%和3.9%至77.8%, 患有AMD、青光眼和DR的人中痴呆症的发病率分别为9.9%至62.6%、2.5%至3.3%和12.5%。 结论: 眼病合并认知障碍或痴呆的频率差异性大。虽然需要更多基于人口的共病估计, 但跨学科合作可能有助于管理这些疾病以满足老龄化人口的医疗保健需求。.

Autres résumés

Type: Publisher (chi)
摘要: 目的: 我们旨在量化老年黄斑变性 (AMD) 、青光眼或糖尿病视网膜疾病合并认知障碍或痴呆情况。 方法: 本文检索了MEDLINE、EMBASE、PsycINFO和CINAHL (至2020年6月) 数据库。观察性研究报道了认知障碍或痴呆患者中AMD、青光眼或糖尿病视网膜病变 (DR) 的发病率或流行率, 以及AMD、青光眼或DR患者中认知障碍或痴呆的情况。 结果: 本文共纳入了56项研究 (57份报告), 这些研究在疾病的诊断标准或定义、研究设计和病例组合方面存在着异质性。很少研究报告发病率。虽然证据少, 但在轻度认知障碍者中的证据是连续的, 观察到7.7%的青光眼发病率。认知障碍者中AMD和DR的患病率分别为3.9%至9.4%和11.4%至70.1%。痴呆症患者中AMD和青光眼的患病率分别为1.4%至53%和0.2%至25.9%。痴呆症患者中DR的患病率为11%。 患有AMD、青光眼和DR的人中认知障碍的发病率分别为8.4%至52.4%、12.3%至90.2%和3.9%至77.8%, 患有AMD、青光眼和DR的人中痴呆症的发病率分别为9.9%至62.6%、2.5%至3.3%和12.5%。 结论: 眼病合并认知障碍或痴呆的频率差异性大。虽然需要更多基于人口的共病估计, 但跨学科合作可能有助于管理这些疾病以满足老龄化人口的医疗保健需求。.

Identifiants

pubmed: 36922645
doi: 10.1038/s41433-023-02481-4
pii: 10.1038/s41433-023-02481-4
pmc: PMC10564749
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3128-3136

Informations de copyright

© 2023. The Author(s).

Références

Ophthalmology. 2019 Apr;126(4):497-510
pubmed: 30114417
Front Aging Neurosci. 2017 Jul 06;9:214
pubmed: 28729832
Acta Ophthalmol. 2012 Nov;90(7):683-5
pubmed: 21332678
J Clin Epidemiol. 2012 Sep;65(9):934-9
pubmed: 22742910
Sci Rep. 2018 Jul 24;8(1):11161
pubmed: 30042382
Diabetes Res Clin Pract. 2012 May;96(2):101-10
pubmed: 22154373
Curr Med Res Opin. 2017 Aug;33(8):1511-1516
pubmed: 28436278
Front Aging Neurosci. 2019 Dec 20;11:363
pubmed: 31920631
Int Psychogeriatr. 2017 May 29;:1-7
pubmed: 28552085
Prog Retin Eye Res. 2011 Jul;30(4):217-38
pubmed: 21440663
Ophthalmic Epidemiol. 2012 Oct;19(5):285-92
pubmed: 22978529
Am J Ophthalmol. 2020 Feb;210:41-47
pubmed: 31712068
Neurology. 1986 Feb;36(2):209-11
pubmed: 3945392
Alzheimers Dement (Amst). 2015 Apr 23;1(2):144-51
pubmed: 27239502
Arch Ophthalmol. 2009 May;127(5):667-73
pubmed: 19433718
Diabetes Metab Syndr Obes. 2020 Apr 24;13:1359-1365
pubmed: 32425568
J Alzheimers Dis. 2014;42(3):909-14
pubmed: 25024309
Diabetes Care. 2013 Oct;36(10):3177-86
pubmed: 23633523
Br J Ophthalmol. 2019 Nov;103(11):1605-1609
pubmed: 31645330
BMJ Open. 2019 Mar 23;9(3):e024209
pubmed: 30904848
PLoS One. 2016 Jan 15;11(1):e0147160
pubmed: 26771382
Ann Transl Med. 2020 Feb;8(4):104
pubmed: 32175397
Neurology. 2018 Mar 27;90(13):e1158-e1166
pubmed: 29490915
JAMA Ophthalmol. 2014 Jan;132(1):63-8
pubmed: 24232933
Sci Rep. 2017 Aug 2;7(1):7095
pubmed: 28769097
J Alzheimers Dis. 2014;42 Suppl 3:S109-17
pubmed: 24625797
Arch Ophthalmol. 2012 Jul;130(7):895-900
pubmed: 22410630
J Glaucoma. 2007 Jan;16(1):47-51
pubmed: 17224749
PLoS One. 2019 Sep 30;14(9):e0223199
pubmed: 31568508
Alzheimers Dement. 2014 Mar;10(2):135-42
pubmed: 24439169
Diabetes Res Clin Pract. 2014 Dec;106(3):465-73
pubmed: 25451914
J Neurol Sci. 2006 Jul 15;246(1-2):79-83
pubmed: 16564058
PLoS One. 2015 Mar 06;10(3):e0120003
pubmed: 25748702
J Diabetes Res. 2014;2014:179648
pubmed: 25431771
Medicine (Baltimore). 2016 Feb;95(7):e2833
pubmed: 26886642
Metab Brain Dis. 2016 Apr;31(2):257-66
pubmed: 26432692
Neurology. 2002 Nov 26;59(10):1536-40
pubmed: 12451193
Am J Epidemiol. 1999 Nov 1;150(9):963-8
pubmed: 10547142
Br J Ophthalmol. 2015 Apr;99(4):524-7
pubmed: 25370081
J Glaucoma. 2013 Jun-Jul;22 Suppl 5:S36-8
pubmed: 23733125
Aging Clin Exp Res. 2011 Oct-Dec;23(5-6):343-50
pubmed: 22526069
Ophthalmology. 2012 Oct;119(10):2094-101
pubmed: 22705343
J Glaucoma. 2019 Aug;28(8):685-690
pubmed: 31033782
J Alzheimers Dis. 2020;76(1):207-215
pubmed: 32444545
Alzheimers Dement (Amst). 2018 Feb 07;10:196-209
pubmed: 29780864
Int J Environ Res Public Health. 2020 Apr 02;17(7):
pubmed: 32252450
J Alzheimers Dis. 2021;83(3):1073-1087
pubmed: 34397414
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13444-9
pubmed: 17684098
Eye (Lond). 2015 Oct;29(10):1340-6
pubmed: 26160529
Invest Ophthalmol Vis Sci. 2015 Feb 03;56(2):1217-21
pubmed: 25650424
Nat Rev Neurosci. 2019 Jan;20(1):19-33
pubmed: 30467385
Acta Ophthalmol Scand. 2004 Aug;82(4):401-4
pubmed: 15291932
Ophthalmology. 2010 Nov;117(11):2088-95
pubmed: 20570357
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
Alzheimers Dement. 2010 Jul;6(4):334-41
pubmed: 20434960
Niger J Clin Pract. 2015 Nov-Dec;18(6):786-9
pubmed: 26289518
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Alzheimers Dement. 2012 Jan;8(1):14-21
pubmed: 22265588
Can J Neurol Sci. 2014 Mar;41(2):206-9
pubmed: 24534032
J Am Geriatr Soc. 2012 Apr;60(4):644-51
pubmed: 22428535
J ASEAN Fed Endocr Soc. 2017;32(2):145-150
pubmed: 33442098
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
Turk J Med Sci. 2015;45(5):1115-21
pubmed: 26738356
Invest Ophthalmol Vis Sci. 2013 Jan 28;54(1):799-803
pubmed: 23307956
Ophthalmology. 2015 Nov;122(11):2327-2335.e2
pubmed: 26337003
Alzheimer Dis Assoc Disord. 2018 Apr-Jun;32(2):125-130
pubmed: 29261519
BMJ Open. 2018 Nov 5;8(11):e022987
pubmed: 30397009
PLoS One. 2014 Oct 02;9(9):e108938
pubmed: 25275530
Eur Neurol. 2002;47(3):165-8
pubmed: 11914555
Br J Ophthalmol. 2019 Dec;103(12):1777-1783
pubmed: 31000510
BMC Ophthalmol. 2015 Mar 11;15:24
pubmed: 25880776
J Diabetes Investig. 2015 Jan;6(1):21-3
pubmed: 25621129
Diabetologia. 2008 Feb;51(2):241-8
pubmed: 18060658
Sci Rep. 2019 Jun 18;9(1):8698
pubmed: 31213626
Gerontology. 2006;52(6):353-8
pubmed: 16902306
Front Aging Neurosci. 2014 Nov 07;6:309
pubmed: 25426067
J Clin Epidemiol. 2002 Sep;55(9):909-15
pubmed: 12393079
Med Hypotheses. 2011 Oct;77(4):591-2
pubmed: 21764520
Asia Pac J Ophthalmol (Phila). 2014 Jan-Feb;3(1):17-22
pubmed: 26107302
Eur Rev Med Pharmacol Sci. 2014 Oct;18(20):3025-8
pubmed: 25392099

Auteurs

Ying Xu (Y)

Neuroscience Research Australia, Sydney, NSW, Australia. y.xu@neura.edu.au.
School of Psychology, Faculty of Science, UNSW, Sydney, NSW, Australia. y.xu@neura.edu.au.
The George Institute for Global Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia. y.xu@neura.edu.au.
Faculty of Medicine, UNSW, Sydney, NSW, Australia. y.xu@neura.edu.au.
Ageing Futures Institute, UNSW, Sydney, NSW, Australia. y.xu@neura.edu.au.

Jack Phu (J)

Centre for Eye Health, UNSW, Sydney, NSW, Australia.
School of Optometry and Vision Science, UNSW, Sydney, NSW, Australia.
Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Concord Clinical School, Concord Repatriation General Hospital, Sydney, NSW, Australia.

Htein Linn Aung (HL)

Neuroscience Research Australia, Sydney, NSW, Australia.
Faculty of Medicine, UNSW, Sydney, NSW, Australia.

Negin Hesam-Shariati (N)

Neuroscience Research Australia, Sydney, NSW, Australia.
School of Psychology, Faculty of Science, UNSW, Sydney, NSW, Australia.

Lisa Keay (L)

The George Institute for Global Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia.
Ageing Futures Institute, UNSW, Sydney, NSW, Australia.
School of Optometry and Vision Science, UNSW, Sydney, NSW, Australia.

Phillip J Tully (PJ)

School of Psychology, The University of New England, Armidale, NSW, Australia.

Andrew Booth (A)

School of Health and Related Research, University of Sheffield, Sheffield, UK.

Craig S Anderson (CS)

The George Institute for Global Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia.
Faculty of Medicine, UNSW, Sydney, NSW, Australia.
The George Institute for Global Health, Beijing, P.R. China.
Neurology Department, Royal Prince Alfred Hospital, Sydney Local Area Health District, Sydney, NSW, Australia.

Kaarin J Anstey (KJ)

Neuroscience Research Australia, Sydney, NSW, Australia.
School of Psychology, Faculty of Science, UNSW, Sydney, NSW, Australia.
Ageing Futures Institute, UNSW, Sydney, NSW, Australia.

Ruth Peters (R)

Neuroscience Research Australia, Sydney, NSW, Australia.
School of Psychology, Faculty of Science, UNSW, Sydney, NSW, Australia.
The George Institute for Global Health, Faculty of Medicine, UNSW, Sydney, NSW, Australia.
Faculty of Medicine, UNSW, Sydney, NSW, Australia.
Ageing Futures Institute, UNSW, Sydney, NSW, Australia.
School of Public Health, Imperial College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH